Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 23 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT07323654
- Conditions
- Eosinophilia, Eosinophilic Asthma, Hematologic Diseases, +6 more
- Locations
-
- Kymera Investigative Site Lancaster, California, United States
- Kymera Investigative Site Long Beach, California, United States
- Kymera Investigative Site Northridge, California, United States
- Kymera Investigative Site Redding, California, United States
Not Yet Recruiting
Fasenra: An Asthma Study
NCT07654842
- Conditions
- Asthma, Bronchial Diseases, Eosinophilia, +15 more
- Locations
-
- Endeavor Health Skokie, Illinois, United States
Not Yet Recruiting
Nasal Inflammation Following Endotoxin Challenge in Patients With Asthma
NCT06270576
- Conditions
- Asthma, Asthma; Eosinophilic, Bronchial Diseases, +13 more
- Locations
-
- National Jewish Health Denver, Colorado, United States
Completed
Changes in Gene Transcription and Immunophenotypes Following Mepolizumab Treatment for Asthma
NCT05002621
- Conditions
- Eosinophilia, Eosinophilic Asthma, Hematologic Diseases, +6 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT05552508
- Conditions
- Asthma, Bronchial Diseases, Eosinophilia, +12 more
- Locations
-
- Research Site Walnut Creek, California, United States
- Research Site Loxahatchee Groves, Florida, United States
- Research Site Plantation, Florida, United States
- Research Site Greenwood, Indiana, United States
NCT03469934
- Conditions
- Eosinophilia, Eosinophilic Asthma, Hematologic Diseases, +6 more
- Locations
-
- Midwest Allergy Sinus Asthma Normal, Illinois, United States
- Pulmonary & Critical Care Specialists Novi, Michigan, United States
- OK Clinical Research, LLC Edmond, Oklahoma, United States
- Allergy & Asthma Center of Southern Oregon Medford, Oregon, United States
NCT03099096
- Conditions
- Asthma, Bronchial Diseases, Eosinophilia, +12 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Scottsdale, Arizona, United States
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site San Diego, California, United States
NCT05180357
- Conditions
- Eosinophilia, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- Research Site Centennial, Colorado, United States
- Research Site Denver, Colorado, United States
- Research Site Glendale, New York, United States
- Research Site New York, United States
NCT04046939
- Conditions
- Asthma, Bronchial Diseases, Eosinophilia, +13 more
- Locations
-
- Research Site Los Angeles, California, United States
- Research Site Mission Viejo, California, United States
- Research Site Westminster, California, United States
- Research Site Denver, Colorado, United States
Completed
A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma
NCT01285323
- Conditions
- Eosinophilia, Eosinophilic Asthma, Hematologic Diseases, +6 more
- Locations
-
- Teva Investigational Site 48 Mobile, Alabama, United States
- Teva Investigational Site 41 Fresno, California, United States
- Teva Investigational Site 59 Long Beach, California, United States
- Teva Investigational Site 47 Denver, Colorado, United States
NCT01287039
- Conditions
- Eosinophilia, Eosinophilic Asthma, Hematologic Diseases, +6 more
- Locations
-
- Teva Investigational Site 58 Scottsdale, Arizona, United States
- Teva Investigational Site 61 Los Angeles, California, United States
- Teva Investigational Site 37 Orange, California, United States
- Teva Investigational Site 56 San Diego, California, United States
NCT03683576
- Conditions
- Asthma, Bronchial Diseases, Eosinophilia, +12 more
- Locations
-
- Clinical Research Center of Albama, LLC Birmingham, Alabama, United States
- Banner University of Arizona Medical Center Tucson, Arizona, United States
- California Allergy and Asthma Medical Group Los Angeles, California, United States
- Southern California Institute for Respiratory Diseases, Inc. Los Angeles, California, United States
Completed
Cessation Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma Patients
NCT02555371
- Conditions
- Asthma, Bronchial Diseases, Eosinophilia, +12 more
- Locations
-
- GSK Investigational Site Long Beach, California, United States
- GSK Investigational Site Riverside, California, United States
- GSK Investigational Site Denver, Colorado, United States
- GSK Investigational Site New Haven, Connecticut, United States
Completed
Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Subcutaneously in Children
NCT02377427
- Conditions
- Asthma, Bronchial Diseases, Eosinophilia, +12 more
- Locations
-
- GSK Investigational Site San Diego, California, United States
- GSK Investigational Site Oklahoma City, Oklahoma, United States
- GSK Investigational Site Medford, Oregon, United States
- GSK Investigational Site Madison, Wisconsin, United States
Completed
A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects
NCT02135692
- Conditions
- Asthma, Bronchial Diseases, Eosinophilia, +12 more
- Locations
-
- GSK Investigational Site Newport Beach, California, United States
- GSK Investigational Site Riverside, California, United States
- GSK Investigational Site Rolling Hills Estates, California, United States
- GSK Investigational Site Denver, Colorado, United States
NCT02654145
- Conditions
- Asthma, Bronchial Diseases, Eosinophilia, +12 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Riverside, California, United States
- GSK Investigational Site Roseville, California, United States
- GSK Investigational Site San Diego, California, United States
NCT03021304
- Conditions
- Asthma, Bronchial Diseases, Eosinophilia, +12 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site Cincinnati, Ohio, United States
- GSK Investigational Site Orangeburg, South Carolina, United States
NCT02281318
- Conditions
- Asthma, Bronchial Diseases, Eosinophilia, +12 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Fresno, California, United States
- GSK Investigational Site Long Beach, California, United States
NCT01508936
- Conditions
- Eosinophilia, Eosinophilic Asthma, Hematologic Diseases, +6 more
- Locations
-
- Investigational Site 861 Birmingham, Alabama, United States
- Investigational Site 842 Homewood, Alabama, United States
- Investigational Site 887 Jasper, Alabama, United States
- Investigational Site 809 Tucson, Arizona, United States
NCT01270464
- Conditions
- Eosinophilia, Eosinophilic Asthma, Hematologic Diseases, +6 more
- Locations
-
- Teva Investigational Site 12 Anaheim, California, United States
- Teva Investigational Site 11 Fountain Valley, California, United States
- Teva Investigational Site 43 Los Angeles, California, United States
- Teva Investigational Site 4 Orange, California, United States